reasonoffering

279 results found.

Top Stocks matching your search for "reason offering"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 9, 2023

Hold .. no reason not too !! !

Nov, 22, 2022

$PALI FAST TRACK FOR REASON 😉

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

Image with triangles

Divihomes is Now Live

Check out our new advanced search tool that can help you find the best home services in your area.

Search & Match

Instant Communication

Phone Image with DiviHomes website

Unbiased Reviews

100% Free

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 1, 2023

I have a really nice position here and no reason t... See more

Dec, 30, 2022

this is a goldmine at these prices and no reason t... See more

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 9, 2023

Hold .. no reason not too !! !

Nov, 22, 2022

$PALI FAST TRACK FOR REASON 😉

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 1, 2023

I have a really nice position here and no reason to sell, probably going to $30-$50 sometime this year if there’s no buyout.

Dec, 30, 2022

this is a goldmine at these prices and no reason there shouldn't be a buyout.